![Matthias Will](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Will
Corporate Officer/Principal presso
AUTOLUS THERAPEUTICS PLC
Patrimonio netto: - $ in data 31/05/2026
Profilo
Matthias Will currently works at Autolus Therapeutics Plc, as Chief Development Officer from 2024.
Dr. Will also formerly worked at Dren Bio, Inc., as Chief Medical Officer, CytomX Therapeutics, Inc., as Head-Clinical Development, and CRISPR Therapeutics, Inc., as Vice President-Clinical Development Officer.
Dr. Will received his graduate degree from Hannover Medical School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Matthias Will
| Società | Posizione | Inizio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 30/09/2024 |
Precedenti posizioni note di Matthias Will
| Società | Posizione | Fine |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Corporate Officer/Principal | - |
| CYTOMX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Matthias Will
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
3
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody therapeutics for cancer, autoimmune and neurology | Health Technology |
